Quantum Biopharma Ltd. | WebDisclosure

COMMUNIQUÉ DE PRESSE

publié le 07/09/2024 à 01:30, il y a 1 année 2 mois

Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
Quantum BioPharma announces Nasdaq compliance and completion of debt settlements with executives. Initiates Class A Share offering. Grants options and RSUs. Cancels warrants and gives forward-looking information

Nasdaq Compliance Debt Settlements Class A Shares Forward-looking Information Quantum BioPharma
BRÈVE

publiée le 30/08/2024 à 13:35, il y a 1 année 3 mois

Quantum BioPharma lance unbuzzd™ sur Amazon

Unbuzzd™ Biopharmacie Quantique Guérison De L'alcoolisme Lancement D'Amazon Nutrition Cellulaire
BRÈVE

publiée le 30/08/2024 à 13:35, il y a 1 année 3 mois

Quantum BioPharma Launches unbuzzd™ on Amazon

Unbuzzd™ Celly Nutrition Alcohol Recovery Quantum BioPharma Amazon Launch
COMMUNIQUÉ DE PRESSE

publié le 30/08/2024 à 13:30, il y a 1 année 3 mois

Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT"
Quantum BioPharma announces the launch of unbuzzd™ Clear Eyed Citrus Powder Sticks, a product designed to help with alcohol recovery and focus on what's next. Celly Nutrition Corp partners debut this groundbreaking solution on Amazon.com

Alcohol Recovery Unbuzzd Celly Nutrition Corp Quantum BioPharma Amazon.com
BRÈVE

publiée le 24/08/2024 à 01:35, il y a 1 année 3 mois

Quantum Biopharma Announces Management Changes and Debt Settlement Plans

Debt Settlement Restricted Share Units Management Changes Quantum BioPharma Option Cancellation
BRÈVE

publiée le 24/08/2024 à 01:35, il y a 1 année 3 mois

Quantum Biopharma annonce des changements de direction et des plans de règlement de la dette

Changements De Direction Unités D'actions Restreintes Biopharmacie Quantique Règlement De Dette Annulation D'option
COMMUNIQUÉ DE PRESSE

publié le 24/08/2024 à 01:30, il y a 1 année 3 mois

Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
Quantum BioPharma announces management changes, option cancellation, RSU grant, debt settlement, and related party transaction. Details on new roles and financial updates

Debt Settlement Financial Updates Related Party Transaction Management Changes Quantum BioPharma

Publié le 04/12/2025 à 18:14, il y a 13 heures 37 minutes

Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 52 minutes

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 52 minutes

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 7 minutes

Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 7 minutes

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

Voir tout LES ECHOS COMFI WIRE

Publié le 05/12/2025 à 02:35, il y a 5 heures 17 minutes

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 02:30, il y a 5 heures 22 minutes

Klondike Gold Announces AGM Results
Publié le 05/12/2025 à 01:00, il y a 6 heures 52 minutes

BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 47 minutes

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 52 minutes

NXT Energy Solutions Completes Data Acquisition for SFD Survey

Voir tout ACCESSWIRE

Publié le 05/12/2025 à 07:00, il y a 52 minutes

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 21 minutes

CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 8 heures 1 minute

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 26 minutes

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 37 minutes

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Voir tout EQS

News